Felix from Norway

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Canopy Growth Corp. (CGC) shares information

Canopy Growth Corp.


24h Change

11.54 %

CGC

Live rate: Market closed

Stock data per Monday 19 Oct, 2020

CGC
New York Stock Exchange
17.76
17.88
19.81
2.05 (+ 11.54%)
US Market is closed

Live Stock price in graph for Canopy Growth Corp. (CGC)

  • Latest Volume

    14,325,645 (417.82 %)

  • Volume prev. day

    2,766,544

  • Avg. daily volume

    5,038,459

  • Market cap

    7,354,898,320

  • P/E ratio

    -4.88

  • Today high

    19.87

  • Today low

    17.66

  • 52 week high

    25.97

  • 52 week low

    9

  • YTD Change

    n/a

Quick links

Broker recommendations for Canopy Growth Corp.

The Canopy Growth Corp. stock is rated at 1.880952 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Thursday 8 October, 2020 by a total of 21 brokers. This means that the consensus of the 21 different brokers is leaning toward to moderate buy/hold.

Sell
2 (9.52%)
Underweight
0 (0%)
Hold
14 (66.67%)
Overweight
1 (4.76%)
Buy
4 (19.05%)

Price target by analysts

The 19 latest analyst estimates, per Monday 12 October, 2020, show the following high, low and average price targets.
Target Average: 17.95 USD
Target High: 23 USD
Target Low: 13.76 USD

 

Latest news about Canopy Growth Corp.

Below you can find the most recent news posts about Canopy Growth Corp., primarily from US and UK based news sources.

Canopy Growth (TSX:CGC): Mexico Could Legalize Marijuana in 2020!

Saturday, 17 October 2020, 16:30:52
Investor sentiment about Canopy Growth (TSX:WEED)(NYSE:CGC) stock is about as bleak as it’s ever been. This could be the perfect time to buy before Mexico legalizes marijuana. The post Canopy Growth (TSX:CGC): Mexico Could Legalize Marijuana in 2020! appeared first on The Motley Fool Canada .
— The Motley Fool Canada


Is Canopy Growth Stock a Buy? | The Motley Fool

Saturday, 17 October 2020, 13:12:00
It’s a leader among cannabis companies, but a laggard when it comes to breaking even on the bottom line.
— The Motley Fool


How Berner’s Cookies Preserves Cannabis Quality Across State Lines

Friday, 16 October 2020, 16:55:48
As a cannabis entrepreneur, getting complimented by Bruce Linton can surely be something to brag about. If the executive chairman of Gage Cannabis — and former CEO of Canopy Growth Corp (NYSE: CGC ) — praises your business decisions, it’s likely a sign you’re on the right track. But if you’re a Billboard-charting rapper like Berner, you might be used to being praised. In a fireside chat at the Benzinga Cannabis Capital Conference on Thursday, Linton said that Berner opened his eyes to the fact that focusing on genetics and breeding drives market share, because consumers want new and better cannabis products. The Cookies, Gage Cannabis Partnership: For Linton, Berner’s brand Cookies stands out in the cannabis landscape for its ability to create a premium brand around flower. That might explain … Full story available on Benzinga.com
— Benzinga


‘Psychedelics renaissance’: Startups turning magic mushrooms into medicine are racing to go public

Thursday, 15 October 2020, 16:37:00
Summary List Placement The psychedelics industry is booming. Compass Pathways , a London-based psychedelics giant, raised $146.6 million in its US initial public offering last month, and is valued at more than $1 billion. Psychedelics companies Field Trip Health and Havn Life Sciences recently started trading in Canada, following MindMed, which secured a Canadian listing in March. Meanwhile, the psychedelics industry is drawing attention from biotech investors , as well as from cannabis companies looking for fresh opportunities. The total market for psychedelics-related medicines could eventually reach $100 billion, according to a report from Tania Gonsalves at Cannacord Genuity. Companies are working on psychedelics-based therapies for treatment-resistant depression, cluster headaches, opioid use disorder, smoking cessation, and PTSD among others, according to the report. Ronan Levy, the founder and executive chairman of Field Trip , which is focused on setting up treatment clinics and on psychedelics-based drug development and manufacturing, called the uptick in investor interest and funding a “psychedelic renaissance.” A focus on the importance of mental health has gone mainstream, Levy said.
— Business Insider


Medical Cannabis Market (Covid 19 Update) Emerging Technology, Investor Analysis and Worldwide Forecast till 2027 || Canopy Growth Corporation, GW Pharmaceuticals plc., Aurora Cannabis., Aphria Medical Cannabis

Wednesday, 14 October 2020, 11:26:37
Data Bridge Market Research has recently added a concise research on the Medical cannabis market to depict valuable insights related to significant market trends driving the industry. Medical cannabis market report comprises of crucial aspects of the market that contains industry research, market
— OpenPR


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CGC available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.